Skip to main content
. 2023 Feb 2;9:1070497. doi: 10.3389/fmed.2022.1070497

TABLE 2.

Lutathera revenue and estimated number of doses and treatments for the period 2018–2021.

Years Lutathera revenue ($ million) ASP per dose ($) Implied number of Lutathera doses Implied number of treatments (4 doses per treatment)
2018 167 20,000 8,350 2,088
2019 441 20,000 22,050 5,513
2020 445 20,000 22,250 5,563
2021 475 20,000 23,750 5,938

Source: (93), Novartis annual report 2021.